Characteristics of the endometrial estrogen-receptor system in physiological and various pathological states of the body
Alekseeva, M.L.; Adamian, L.V.; Slurchak, S.V.; Strizhakov, A.N.; Novikov, E.A.
Problemy Endokrinologii 26(4): 26-28
1980
ISSN/ISBN: 0375-9660 PMID: 7413610 Document Number: 168472
The state of endometrial estrogen-receptor systems was evaluated under physiological and pathological conditions characterized by changes in estradiol dynamics during the menstrual cycle. It is suggested that external endometriosis is accompanied by changes in the state of the endometrial estrogen-receptor level. (Author's Modified)
Document emailed within 1 workday
Related Documents
Echeverría, O.M.; Thampan, R.V.; Juárez-Chavero, S.; Hernández-Pérez, A.D.; Ortiz, R.; Vázquez-Nin, G.H. 2005: Immunocytochemical study of estrogen receptor activation factor (E-RAF) and the proteins that interact with nuclear estrogen receptor II (nER II) in epithelial endometrial cells, in the presence and in the absence of estradiol European Journal of Histochemistry: Ejh 49(1): 67-74Shiozawa, T.; Itoh, K.; Horiuchi, A.; Konishi, I.; Fujii, S.; Nikaido, T. 2002: Down-regulation of estrogen receptor by the methylation of the estrogen receptor gene in endometrial carcinoma Anticancer Research 22(1a): 139-143
Segreti, E.M.; Novotny, D.B.; Soper, J.T.; Mutch, D.G.; Creasman, W.T.; McCarty, K.S. 1989: Endometrial cancer: histologic correlates of immunohistochemical localization of progesterone receptor and estrogen receptor Obstetrics and Gynecology 73(5 Pt 1): 780-785
Ferguson, A.T.; Lapidus, R.G.; Baylin, S.B.; Davidson, N.E. 1995: Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression Cancer Research 55(11): 2279-2283
Fontana, F.; Bernardi, P.; Puddu, P.; Lenzi, S. 1990: Atrial natriuretic factor in physiological conditions and pathological states La Clinica Terapeutica 134(6): 371-382
Malarewicz, A.; Chróściel, M. 1988: Cancer of the uterine body and pathological endometrial hyperplasia Wiadomosci Lekarskie 41(6): 368-372
Miecznikowski, A.; Schmidt, M. 1972: The activity of lysosomal hydrolases in amniotic fluid in physiological and pathological states Przeglad Lekarski 29(12): 952-955
Ametov, A.S.; Zavadenko, N.N.; Temin, P.A. 1988: Metabolism of steroid sex hormones in different physiological and pathological states of the skeletal muscles Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 88(3): 125-131
Rosen, P.P.; Menendez-Botet, C.J.; Nisselbaum, J.S.; Urban, J.A.; Miké, V.; Fracchia, A.; Schwartz, M.K. 1975: Pathological review of breast lesions analyzed for estrogen receptor protein Cancer Research 35(11 Part 1): 3187-3194
Wu, X.; Liu, X.; Jin, X.; Xu, X. 2014: Effects of levonorgestrel intrauterine system on the expressions of estrogen receptor, progesterone receptor and insulin-like growth factor-1 Zhonghua Yi Xue Za Zhi 94(35): 2763-2765
Corenblum, B.; Donovan, L. 1993: The safety of physiological estrogen plus progestin replacement therapy and with oral contraceptive therapy in women with pathological hyperprolactinemia Fertility and Sterility 59(3): 671-673
Kahán, Z. 1996: Current questions about estrogen receptor determination and hormone dependence (does estrogen receptor positivity equal estrogen dependence?) Orvosi Hetilap 137(42): 2305-2308
Yanaranop, M.; Ayuwat, S.; Nakrangsee, S. 2016: Differential Diagnosis between Primary Endocervical and Endometrial Adenocarcinoma using Immunohistochemical Staining of Estrogen Receptor, Vimentin, Carcinoembryonic Antigen and p16 Journal of the Medical Association of Thailand 99(Suppl 2): S106-S115
Hirose, T.; Kimura, J.; Okada, H. 1985: Simultaneous measurements of nucleic acids and estrogen receptor in human endometrial adenocarcinoma cell lines by flow cytometry Nihon Sanka Fujinka Gakkai Zasshi 37(10): 2133-2134
Piranić, H.; Mladenović, Z. 1975: Difficult opening of the oral cavity as a symptom of various pathological states of the body Medicinski Pregled 28(11-12): 525-527
Roberts, M.L.; Mashford, M.L. 1972: Possible physiological and pathological roles of the kallikrein-kinin system Medical Journal of Australia 2(16): 887-891
Nizamutdinova, I.T.; Lee, G.W.; Son, K.H.; Jeon, S.J.; Kang, S.S.; Kim, Y.S.; Lee, J.H.; Seo, H.G.; Chang, K.C.; Kim, H.J. 2008: Tanshinone i effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells International Journal of Oncology 33(3): 485-491
Castles, C.G.; Fuqua, S.A.; Klotz, D.M.; Hill, S.M. 1993: Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line Cancer Research 53(24): 5934-5939
Horwitz, K.B.; McGuire, W.L. 1978: Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor Journal of Biological Chemistry 253(7): 2223-2228
Kotula-Balak, M.; Gancarczyk, M.; Sadowska, J.; Bilinskai, B. 2005: The expression of aromatase, estrogen receptor alpha and estrogen receptor beta in mouse Leydig cells in vitro that derived from cryptorchid males European Journal of Histochemistry: Ejh 49(1): 59-62